Business

Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call

LOS ANGELES--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics

articleVivani Medical, Inc.November 5, 20194/company/vivani-medical-inc/news/second-sight-to-discuss-third-quarter-2019-financial-results-on-november-14-2019-conference-call
Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call

About this update from Vivani Medical, Inc.

[{"type":"text","content":" LOS ANGELES--(BUSINESS WIRE)--\nSecond Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will release its financial results for the third quarter of 2019 on Thursday, November 14, 2019, after the close of the U.S. financial markets.\n\n\nWill McGuire, President and Chief Executive Officer, and John T. Blake, Chief Financial Officer, will host a conference call to discuss the results as follows:\n\n\n\n \n\nDate\n\n\n\nThursday, November 14, 2019\n\n\n\n\n \n\nTime\n\n\n\n4:30 p.m. EST\n\n\n\n\n \n\nToll free (U.S.)\n\n\n\n(800) 771-6759\n\n\n\n\n \n\nInternational\n\n\n\n(212) 231-2937\n\n\n\n\n \n\nWebcast (live and replay)\n\n\n\nwww.secondsight.com under the ‘Investors’ section.\n\n\n\n\n\nA replay of the conference call will be available for two weeks after the call's completion by dialing (800) 633-8284 (U.S.) or (402) 977-9140 (International). The conference ID for the replay is 21933121. The archived webcast will be available for 30 days via the aforementioned URL.\n\n\nAbout Second Sight\n\n\nSecond Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company’s U.S. headquarters are in Los Angeles, California, and European headquarters are in Lausanne, Switzerland. More information is available at www.secondsight.com.\n\n\nSafe Harbor \n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the “safe harbor” created by those sections. All statements in this release that are not based on historical fact are “forward looking statements.” These statements may be identified by words such as “estimates,” “anticipates,” “projects,” “plans,” “strategy,” “goal,” or “planned,” “seeks,” “may,” “will,” “expects,” “intends,” “believes,” “should,” and similar expressions, or the n...

More updates from Vivani Medical, Inc.